Insider Transactions in Q4 2021 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Pierre Legault Director |
SELL
Open market or private sale
|
Direct |
97,860
-100.0%
|
$5,675,880
$58.01 P/Share
|
|
Dec 22
2021
|
Pierre Legault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
97,860
+50.0%
|
$782,880
$8.48 P/Share
|
|
Dec 21
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,477
+50.0%
|
$216,678
$14.0 P/Share
|
|
Dec 21
2021
|
Pierre Legault Director |
SELL
Open market or private sale
|
Direct |
44,537
-100.0%
|
$2,538,609
$57.11 P/Share
|
|
Dec 21
2021
|
Pierre Legault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,537
+50.0%
|
$356,296
$8.44 P/Share
|
|
Dec 20
2021
|
Pierre Legault Director |
SELL
Open market or private sale
|
Direct |
7,603
-100.0%
|
$433,371
$57.02 P/Share
|
|
Dec 20
2021
|
Pierre Legault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,603
+50.0%
|
$60,824
$8.41 P/Share
|
|
Oct 18
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
49
-0.02%
|
$2,940
$60.0 P/Share
|
|
Oct 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
320
-0.14%
|
$19,200
$60.05 P/Share
|
|
Oct 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,631
-2.01%
|
$277,860
$60.0 P/Share
|
|
Oct 11
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-1.07%
|
$270,000
$54.22 P/Share
|
|
Oct 05
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,178
-100.0%
|
$98,010
$45.1 P/Share
|
|
Oct 01
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,188
-35.29%
|
$53,460
$45.0 P/Share
|